You are now leaving the Lilly Medical Education website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.
Biomarkers in Alzheimer's Disease
Explore how fluid and imaging biomarkers reflect underlying Alzheimer’s disease biology and may help inform clinical evaluation. This brief resource highlights key markers like Aβ42/Aβ40 and P‑tau and their emerging role across the AD continuum.
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Very Satisfied
Very Dissatisfied
Relevance of the information to my needs
Very Satisfied
Very Dissatisfied
Confidence to implement the learnings in my clinical practice
Very Satisfied
Very Dissatisfied